Manchester Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Manchester Capital Management’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-139	Closed	-$3K	–	1084
2022 Q3	$3K	Buy	139 +20	+17%	+$416	﹤0.01%	620
2022 Q2	$2K	Buy	119 +2	+2%	+$36	﹤0.01%	773
2022 Q1	$2K	Buy	117 +88	+303%	+$1.54K	﹤0.01%	884
2021 Q4	$1K	Sell	29 -75	-72%	-$1.41K	﹤0.01%	994
2021 Q3	$2K	Buy	+104	New	+$2.38K	﹤0.01%	909

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Manchester Capital Management's CVET Position: Q4 2022 in Review

Manchester Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 139 shares — an estimated $3K sold.

Manchester Capital Management first reported a position in CVET in Q3 2021 and held it in 5 quarters. The position peaked at $3K in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Manchester Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Manchester Capital Management sold 139 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3K.
Manchester Capital Management first reported a position in Covetrus, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Manchester Capital Management's Covetrus, Inc. Common Stock position peaked at $3K in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Manchester Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.